For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) closed the day trading at $9.44 down -4.45% from the previous closing price of $9.88. In other words, the price has decreased by -$4.45 from its previous closing price. On the day, 1.26 million shares were traded. ARCT stock price reached its highest trading level at $9.9438 during the session, while it also had its lowest trading level at $9.36.
Ratios:
For a better understanding of ARCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.90 and its Current Ratio is at 5.90. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
On October 23, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 256338736 and an Enterprise Value of 86835752. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.33 while its Price-to-Book (P/B) ratio in mrq is 1.11. Its current Enterprise Value per Revenue stands at 0.711 whereas that against EBITDA is -1.254.
Stock Price History:
The Beta on a monthly basis for ARCT is 2.43, which has changed by -0.4675691 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, ARCT has reached a high of $24.17, while it has fallen to a 52-week low of $8.04. The 50-Day Moving Average of the stock is -48.35%, while the 200-Day Moving Average is calculated to be -36.32%.
Shares Statistics:
Over the past 3-months, ARCT traded about 1.16M shares per day on average, while over the past 10 days, ARCT traded about 3429630 shares per day. A total of 27.15M shares are outstanding, with a floating share count of 24.87M. Insiders hold about 8.42% of the company’s shares, while institutions hold 96.14% stake in the company. Shares short for ARCT as of 1760486400 were 5310305 with a Short Ratio of 4.59, compared to 1757894400 on 5947408. Therefore, it implies a Short% of Shares Outstanding of 5310305 and a Short% of Float of 30.23.
Earnings Estimates
Current recommendations for the stock of the company come from 9.0 analysts. The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.12 and low estimates of -$1.88.
Analysts are recommending an EPS of between -$1.04 and -$4.42 for the fiscal current year, implying an average EPS of -$2.63. EPS for the following year is -$2.35, with 9.0 analysts recommending between $1.41 and -$4.91.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for ARCT’s current fiscal year. The highest revenue estimate was $116.18M, while the lowest revenue estimate was $57.68M, resulting in an average revenue estimate of $88.28M. In the same quarter a year ago, actual revenue was $152.31MBased on 11 analysts’ estimates, the company’s revenue will be $94.63M in the next fiscal year. The high estimate is $279.39M and the low estimate is $14.6M.
